Xyzal Allergy 24HR
NDC 41167-3511, Levocetirizine dihydrochloride, tablet, from Chattem, Inc..
- Product NDC
- 41167-3511
- Status
- Listed
- Labeler
- Chattem, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA209089
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/41167-3511 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 41167-3511-2 | 41167351102 | 1 BLISTER PACK in 1 CARTON (41167-3511-2) / 20 TABLET in 1 BLISTER PACK |
| 41167-3511-8 | 41167351108 | 1 BLISTER PACK in 1 CARTON (41167-3511-8) / 40 TABLET in 1 BLISTER PACK |
| 41167-3511-9 | 41167351109 | 1 BLISTER PACK in 1 CARTON (41167-3511-9) / 60 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 41167-3511 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/41167-3511 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 41167-3511. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.